CareDx, Inc. (NASDAQ:CDNA) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group, IR Reg Seeto - President, CEO Abhishek Jain - CFO Robert Woodward - SVP, R&D Conference Call Participants Matt Sykes - Goldman Sachs Andrew Cooper - Raymond James Brandon Couillard - Jefferies Mark Massaro - BTIG Alex Nowak - Craig-Hallum Capital Group Mason Carrico - Stephens Inc. Operator Greetings. And welcome to the CareDx, Inc. First Quarter 2023 Earnings Con ...

Table of Contents For the transition period from to Commission file number: 001-36536 __________________________________________________ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check m ...

CareDx, Inc. (NASDAQ:CDNA) Q4 2022 Earnings Conference Call February 27, 2023 4:30 PM ET Company Participants Greg Chodaczek - IR Reginald Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants Andrew Cooper - Raymond James Matthew Sykes - Goldman Sachs Mason Carrico - Stephens Alex Nowak - Craig-Hallum Capital Group Mark Massaro - BTIG Yi Chen - H.C. Wainright Operator Good day, ladies and gentlemen, and welcome to the CareDx, Incorporated Fourth Quarter 2022 Earnings Conference Call. Today’s ...

| --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------|-------|-----------|-------|-----------------------------|-------|-------| | | | | | | | | | Focused on improving care across the entire transplant patient journey The Transplant Company Q4 and FY 2022 | ™ | | | | | | | | | Leslie M, | | Kidney Transplant Recipient | | | | Earnings Presentation | | | | | | | Safe Harbor Statement 2023 Focus On The Three ...

Environmental Matters Table of Contents company☐ company☐ Portions of the registrant's Proxy Statement relating to the 2023 Annual Meeting of Stockholders, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Proxy Statement, or an amendment to this Annual Report on Form 10-K, will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant's fiscal year ended December 31, 2022. TABLE OF CONTENTS PART III 127 Item 10. D ...

CareDx, Inc (NASDAQ:CDNA) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Ian Cooney - VP, IR Reg Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants Brandon Couillard - Jefferies Operator Good day, ladies and gentlemen, and welcome to the CareDx, Incorporated Third Quarter 2022 Earnings Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Ian Cooney. Please go ahead. Ian Cooney Good afternoon, and ...

| --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------|-------|-----------|-------|-----------------------------|-------|-------| | | | | | | | | | Focused on improving care across the entire transplant patient journey The Transplant Company Q3 2022 | ™ | | | | | | | | | Leslie M, | | Kidney Transplant Recipient | | | | Earnings Presentation | | | | | | | Safe Harbor Statement These slides and the accompanying ora ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...

CareDx, Inc. (NASDAQ:CDNA) Q2 2022 Results Conference Call August 4, 2022 4:30 PM ET Company Participants Ian Cooney - VP, IR Reg Seeto - CEO Abhishek Jain - Interim CFO Conference Call Participants Andrew Cooper - Raymond James Alex Nowak - Craig-Hallum Capital Group Brandon Couillard - Jefferies Jacob Johnson - Stephens Yi Chen - H.C. Wainwright E.V. Koslosky - Goldman Sachs Operator Good day, and welcome to the CareDx, Inc. Second Quarter 2022 Earnings Call. Today’s conference is being recorded. At this ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...